Liu Wei, Wu You, Hu Yuli, Qin Shuai, Guo Xiaoyuan, Wang Minghui, Wu Lili, Liu Tonghua
Key Laboratory of Health Cultivation of the Ministry of Education, Beijing University of Chinese Medicine, Beijing, China.
Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Front Nutr. 2020 Dec 1;7:605605. doi: 10.3389/fnut.2020.605605. eCollection 2020.
(CP) has been used as an herbal tea to treat diabetes mellitus and obesity for hundreds of years. Previous research suggests that CP specifically restores glucolipid metabolic homeostasis, and the two most studied preparations are aqueous and ethanol extracts. In order to verify the effect of CP on glucolipid metabolism in animal models with metabolic syndrome, a meta-analysis was performed, and the active components and underlying mechanisms were systematically reviewed. Four databases: PubMed, Web of Science, Embase, and Cochrane Library were searched to identify potential literature. Data of blood glucose (BG) level, area under curve (AUC) of oral glucose tolerance test (OGTT), total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL), and low-density lipoprotein (LDL) levels were extracted as indicators of the assessment of CP's effects. Follow-up analyses including subgroup analysis, meta-regressions, and publication bias were also conducted. A total of 96 papers were identified from the databases and 11 papers including 31 data reports were involved in the meta-analysis. CP had a positive effect in down-regulating BG, AUC of OGTT, TC, TG, and LDL, and up-regulating HDL ( < 0.001, 95% confidence interval of standard mean difference did not incorporate the null value 0). CP showed definite activity of regulating glucolipid metabolism in animal models, and it exerted its function through multiple mechanisms including but not limited to: (1) improving insulin resistance; (2) protecting pancreatic β cells; (3) decreasing inflammatory infiltration; and (4) anti-oxidative stress.
数百年来,(某植物)一直被用作治疗糖尿病和肥胖症的草药茶。先前的研究表明,该植物能特异性地恢复糖脂代谢稳态,其中研究最多的两种制剂是水提取物和乙醇提取物。为了验证该植物对代谢综合征动物模型糖脂代谢的影响,我们进行了一项荟萃分析,并对其活性成分和潜在机制进行了系统综述。检索了四个数据库:PubMed、Web of Science、Embase和Cochrane图书馆,以确定潜在的文献。提取血糖(BG)水平、口服葡萄糖耐量试验(OGTT)曲线下面积(AUC)、总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL)和低密度脂蛋白(LDL)水平的数据,作为评估该植物效果的指标。还进行了包括亚组分析、meta回归和发表偏倚在内的随访分析。从数据库中总共识别出96篇论文,其中11篇论文(包括31份数据报告)参与了荟萃分析。该植物在下调BG、OGTT的AUC、TC、TG和LDL以及上调HDL方面具有积极作用(P<0.001,标准平均差的95%置信区间不包含零值0)。该植物在动物模型中显示出明确的调节糖脂代谢的活性,其作用机制包括但不限于:(1)改善胰岛素抵抗;(2)保护胰腺β细胞;(3)减少炎症浸润;(4)抗氧化应激。